Cargando…
Autophagy in Cancer Therapy
Autophagy represents a catabolic program involved in the degradation of cellular components via lysosomes. It serves to mitigate cellular stress and to provide metabolic precursors especially upon starvation. Thereby, autophagy can support the survival of cancer cells. In addition, there is now conv...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475391/ https://www.ncbi.nlm.nih.gov/pubmed/28674677 http://dx.doi.org/10.3389/fonc.2017.00128 |
_version_ | 1783244555530797056 |
---|---|
author | Fulda, Simone |
author_facet | Fulda, Simone |
author_sort | Fulda, Simone |
collection | PubMed |
description | Autophagy represents a catabolic program involved in the degradation of cellular components via lysosomes. It serves to mitigate cellular stress and to provide metabolic precursors especially upon starvation. Thereby, autophagy can support the survival of cancer cells. In addition, there is now convincing evidence showing that under certain conditions autophagy can also foster cell death. This dual function of autophagy is also relevant upon anticancer treatment, as many chemotherapeutic agents engage autophagy. A better understanding of the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells will be instrumental to selectively interfere with this cellular program in order to increase the cancer cell’s response to cytotoxic drugs. This review illustrates how anticancer drug-induced autophagy is involved in mediating cell death. |
format | Online Article Text |
id | pubmed-5475391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54753912017-07-03 Autophagy in Cancer Therapy Fulda, Simone Front Oncol Oncology Autophagy represents a catabolic program involved in the degradation of cellular components via lysosomes. It serves to mitigate cellular stress and to provide metabolic precursors especially upon starvation. Thereby, autophagy can support the survival of cancer cells. In addition, there is now convincing evidence showing that under certain conditions autophagy can also foster cell death. This dual function of autophagy is also relevant upon anticancer treatment, as many chemotherapeutic agents engage autophagy. A better understanding of the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells will be instrumental to selectively interfere with this cellular program in order to increase the cancer cell’s response to cytotoxic drugs. This review illustrates how anticancer drug-induced autophagy is involved in mediating cell death. Frontiers Media S.A. 2017-06-15 /pmc/articles/PMC5475391/ /pubmed/28674677 http://dx.doi.org/10.3389/fonc.2017.00128 Text en Copyright © 2017 Fulda. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Fulda, Simone Autophagy in Cancer Therapy |
title | Autophagy in Cancer Therapy |
title_full | Autophagy in Cancer Therapy |
title_fullStr | Autophagy in Cancer Therapy |
title_full_unstemmed | Autophagy in Cancer Therapy |
title_short | Autophagy in Cancer Therapy |
title_sort | autophagy in cancer therapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475391/ https://www.ncbi.nlm.nih.gov/pubmed/28674677 http://dx.doi.org/10.3389/fonc.2017.00128 |
work_keys_str_mv | AT fuldasimone autophagyincancertherapy |